Introduction
Empirical outpatient treatment options for staphylococcal infections have become more limited as lincosamides, and type B streptogramins (MLS B resistance). 2, 3 When the underlying mechanism of resistance to erythromycin is an altered efflux system, expressed by the msrA/msrB gene, staphylococcal strains are susceptible to clindamycin, whereas ribosomal methylation expressed by the erm gene could render strains resistant to clindamycin. The present study was undertaken to investigate the prevalence of genes encoding resistance to MLS B antibiotics in a series of 301 erythromycin-resistant clinical isolates of S. aureus and CoNS. (Fermentas), 0.2 mM each of dATP, dTTP, dCTP and dGTP (Fermentas), 0.4 mM of the sense and anti-sense primers, 1.25 U Taq DNA polymerase (Fermentas) and 1 μL of extracted template DNA. The PCR were initialized by a denaturation step (5 min at 94°C) followed by 35 cycles of 30 seconds at 95°C, 30 seconds at 54°C, 1 minute at 72°C; and a final extension step (5 min at 72°C). PCR products were detected by gel electrophoresis (100 V, 60 min) in 2% (w/v) agarose gels containing ethidium bromide. The sizes of the PCR products were estimated with standard molecular weight markers (1.5-100 kb DNA ladder; Bio Basic Inc., Ontario, Canada). Isolates were considered positive for erm(A), erm(B), erm(C), msr(A) and msr(B) genes when the respective PCR products of the expected size could be visualized.
Methods

Bacterial isolates
Statistical analysis
Statistical analysis was conducted using Fischer's exact test and χ 2 test. 
Results
MLS B resistance phenotypes
MLS B resistance genotypes
The distribution of resistance genes is presented in the Combinations of resistance mechanisms were rarely seen, and occurred mainly in oxacillin-resistant isolates. Eighty-three of the erythromycin-resistant isolates did not harbor any of the tested resistance mechanisms. Seventyseven of these isolates were CoNS, while only six were S. aureus.
Discussion
While data on genetic determinants of MLS resistance from Turkey are limited to the reports of Aktas et al and Saribas et al, 9, 10 other groups have studied the prevalence of MLS resistance using phenotypic methods in other hospitals from Turkey. [4] [5] [6] [7] [8] While the MLS B resistance rate determined in our hospital was higher than the rate reported by Tunckanat and Arikan, 8 it was lower than the rate reported by Delialioglu et al. 6 Overall, the most frequently determined genetic determinant responsible for MLS B resistance was erm(C), with a constitutive resistance phenotype in our study. This finding was in accordance with previous reports from Turkey. [16] [17] [18] [19] Thus, in conjunction with previous reports, the results of the present study support the hypothesis that there are geographical differences in the prevalence of erythromycin resistance mechanisms among staphylococci. 2 However, we must also mention the fact that since species identification was not performed for CoNS isolates, we cannot exclude the possibility that these differences might be due to variation in the distribution of different species. Most of the isolates from which we were not able to detect any resistance genes were CoNS, and this was in accordance with the previous reports that have found 44 (17) 3 (1) 77 (30) 11 (4) 81 (32) 16 (6) 77 ( 73 (24) 3 (1) 85 (28) 14 (5) 94 (31) 22 (7) 83 (28) a Data presented as n (%). ND = Not detected; S. aureus = Staphylococcus aureus; iMLS = inducible macrolide, lincosamide and streptogramin resistance; cMLS = constitutive macrolide, lincosamide and streptogramin resistance; MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillinsusceptible Staphylococcus aureus; CoNS = coagulase-negative staphylococci; MRCoNS = methicillin-resistant coagulase-negative staphylococci; MSCoNS = methicillin-susceptible coagulase-negative staphylococci.
unidentified resistance mechanisms in a considerable proportion of CoNS isolates. 1 It is likely that other erythromycin resistance genes such as Ere A-B or mef, which we did not include in our study, might be present among these isolates. 3 The main problem among strains that have been detected as erythromycin resistant and clindamycin susceptible by standard antibiotic susceptibility tests is the possibility that these strains may be inducibly resis tant to MLS B antibiotics, since this resistance phenotype can be underestimated if testing for inducible resistance is not performed. Although most erythromycin-resistant isolates in the present study showed constitutive expression of MLS B resistance, 24 (77%) of 31 S. aureus and 49 (34%) of 143 CoNS isolates that were erythromycin resistant and clindamycin susceptible were positive by the D-test. Therefore, we suggest that erythromycin-resistant isolates of S. aureus may also be considered to be clindamycin resistant in most cases. Although clindamycin is reported as one of the therapeutic options in the treatment of MRSA, 20 it seems that we cannot consider this antibiotic as useful in the treatment of hospital-associated MRSA infections. However, the lower positivity rate by the D-test among erythromycin-resistant CoNS made us think that clindamycin should not be considered to be ineffective in these species without testing for inducible resistance. It has been reported that resistance mechanisms other than methylation are more common among CoNS, the assumption being that methylases are responsible for erythromycin resistance in these isolates could lead to an unnecessary avoidance of lincosamides and an increased usage of glycopeptides.
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In conclusion, the most prevalent phenotype among S. aureus was the iMLS B type mediated by the erm(A) gene, while the most prevalent phenotype among CoNS was the cMLS B type mediated by erm(C) gene. These findings with significant geographical differences in resistance patterns and resistance rates make the results of local surveillance studies an important tool in guiding therapy and for judicious use of antimicrobial agents.
